ATE334969T1 - Triptolid-prodrugs mit hoher wasserlöslichkeit - Google Patents

Triptolid-prodrugs mit hoher wasserlöslichkeit

Info

Publication number: ATE334969T1
Authority: AT; Austria
Prior art keywords: water solubility; high water; triptolide; triptolide prodrugs; prodrugs
Prior art date: 1998-09-02

Application number

AT03016090T

Other languages

English (en)

Inventor

John H Musser

Original Assignee

Pharmagenesis Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-09-02

Filing date

1999-09-02

Publication date

2006-08-15

1999-09-02 Application filed by Pharmagenesis Inc filed Critical Pharmagenesis Inc

2006-08-15 Application granted granted Critical

2006-08-15 Publication of ATE334969T1 publication Critical patent/ATE334969T1/de

Links

DFBIRQPKNDILPW-CIVMWXNOSA-N Triptolide Chemical compound O=C1OCC([C@@H]2C3)=C1CC[C@]2(C)[C@]12O[C@H]1[C@@H]1O[C@]1(C(C)C)[C@@H](O)[C@]21[C@H]3O1 DFBIRQPKNDILPW-CIVMWXNOSA-N 0.000 title abstract 2
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 title abstract 2
229940002612 prodrug Drugs 0.000 title 1
239000000651 prodrug Substances 0.000 title 1
YKUJZZHGTWVWHA-UHFFFAOYSA-N triptolide Natural products COC12CC3OC3(C(C)C)C(O)C14OC4CC5C6=C(CCC25C)C(=O)OC6 YKUJZZHGTWVWHA-UHFFFAOYSA-N 0.000 title 1
150000001875 compounds Chemical class 0.000 abstract 3
230000003110 anti-inflammatory effect Effects 0.000 abstract 1
230000001506 immunosuppresive effect Effects 0.000 abstract 1
230000001988 toxicity Effects 0.000 abstract 1
231100000419 toxicity Toxicity 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
- C07D493/12—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains three hetero rings
- C07D493/14—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
Immunology (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Chemical Kinetics & Catalysis (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
General Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Transplantation (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Saccharide Compounds (AREA)
Polysaccharides And Polysaccharide Derivatives (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

AT03016090T 1998-09-02 1999-09-02 Triptolid-prodrugs mit hoher wasserlöslichkeit ATE334969T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US9880998P	1998-09-02	1998-09-02

Publications (1)

Publication Number	Publication Date
ATE334969T1 true ATE334969T1 (de)	2006-08-15

Family

ID=22270998

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
AT03016090T ATE334969T1 (de)	1998-09-02	1999-09-02	Triptolid-prodrugs mit hoher wasserlöslichkeit
AT99949582T ATE245145T1 (de)	1998-09-02	1999-09-02	Gut wasserlösliche triptolid-prodrugs

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
AT99949582T ATE245145T1 (de)	1998-09-02	1999-09-02	Gut wasserlösliche triptolid-prodrugs

Country Status (9)

Country	Link
US (1)	US6150539A (de)
EP (1)	EP1109789B1 (de)
JP (1)	JP2002523495A (de)
CN (1)	CN1316997A (de)
AT (2)	ATE334969T1 (de)
AU (1)	AU764123B2 (de)
CA (1)	CA2342901A1 (de)
DE (2)	DE69932649T2 (de)
WO (1)	WO2000012483A1 (de)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6548537B1 (en) *	1998-09-02	2003-04-15	Pharmagenesis, Inc.	Triptolide prodrugs having high aqueous solubility
CA2376008A1 (en) *	1999-06-02	2000-12-14	Oxford Natural Products Plc	Combination of glucosamine with herbal extracts of tripterygium, ligustrum and erycibe
US6620843B2 (en) *	2001-01-19	2003-09-16	Pharmagenesis	Anticancer treatment using triptolide prodrugs
EP1390358A4 (de) *	2001-03-15	2004-06-16	Pharmagenesis Inc	Aminosäurederivate von triptolidverbindungen als immunmodulatoren und antikrebsmittel
EP2468277A1 (de)	2002-05-31	2012-06-27	Pharmagenesis, Inc.	Triptolidderivate zur Modulierung der Apoptose und Immunsuppression
CN100398544C (zh) *	2002-09-18	2008-07-02	成都达远药物有限公司	高免疫抑制活性的水溶性雷公藤内酯醇衍生物及其应用
WO2004058246A1 (en) *	2002-12-17	2004-07-15	Pharmagenesis, Inc.	Triptolide derivatives as immunomodulator and anticancer agents
US6943259B2 (en) *	2003-02-25	2005-09-13	Pharmagenesis, Inc.	Halogenated triptolide derivatives as immunomodulators and anticancer agents
CN100408583C (zh) *	2003-02-25	2008-08-06	美国泛华医药公司	用作免疫调节剂和抗癌药的卤代雷公藤内酯醇衍生物
WO2005020887A2 (en) *	2003-06-27	2005-03-10	Pharmagenesis, Inc.	Method for treatment of severe acute respiratory syndrome
WO2005062913A2 (en) *	2003-12-24	2005-07-14	Pharmagenesis, Inc.	Triplide 5,6-derivatives as immunomodulators and anticancer agents
EP1722806A4 (de)	2004-02-09	2009-09-16	Pharmagenesis Inc	Verfahren zur isolierung von triptolid-verbindungen aus tripterygium wilfordii
WO2005084365A2 (en)	2004-03-02	2005-09-15	Pharmagenesis, Inc.	Triptolide lactone ring derivatives as immunomodulators and anticancer agents
WO2006012204A2 (en) *	2004-06-25	2006-02-02	Pharmagenesis, Inc.	Method for treatment of inflammatory disorders using triptolide compounds
WO2006044496A2 (en)	2004-10-13	2006-04-27	Pharmagenesis, Inc.	Identification and screening of triptolide target molecules
CN104387406A (zh)	2009-02-05	2015-03-04	药物起源公司	作为抗癌药和免疫调制剂的雷公藤内酯 c-环衍生物
DK2427467T3 (en)	2009-05-07	2015-11-09	Univ Minnesota	Triptolid prodrugs
US9150600B2 (en)	2009-05-07	2015-10-06	Regents Of The University Of Minnesota	Triptolide prodrugs
LT3510860T (lt)	2012-08-23	2021-10-25	Senestech, Inc.	Žinduolių reprodukcinio pajėgumo sumažinimas
WO2014167581A2 (en) *	2013-04-01	2014-10-16	Laurus Labs Private Limited	An improved process for the preparation of triptolide prodrugs
WO2015127011A1 (en)	2014-02-21	2015-08-27	Institute Of Cancer Research D/B/A The Research Institute Of Fox Chase Cancer Center	C-myc as a biomarker for tumor sensitivity to treatment with rna polymerase ii inhibition
JP6738326B2 (ja) *	2014-06-06	2020-08-12	ザスクリプスリサーチインスティテュート	フッ化硫黄（ｖｉ）化合物およびそれの製造方法
CN106883284B (zh) *	2017-03-03	2018-10-16	广东省中医院	雷公藤内酯三醇的快速安全制备方法
CN106995450B (zh) *	2017-05-19	2019-04-02	湖北大学	一种雷公藤甲素衍生物及其制备方法和用途
CN110759929B (zh) *	2018-07-27	2022-05-03	上海医药集团股份有限公司	(5r)-5-羟基雷公藤内酯醇的制备方法
EP4086271B1 (de) *	2019-12-30	2023-12-13	Guangdong Provincial Hospital of TCM	Triptolidylacrylat, verfahren zu seiner herstellung und seine verwendung
US20230303618A1 (en)	2020-08-21	2023-09-28	Reyoung Corporation	Triptolide conjugates and uses thereof
WO2023143330A1 (zh) *	2022-01-25	2023-08-03	杭州卫本医药科技有限公司	具有杀伤myc阳性细胞功能雷公藤二萜类环氧化合物、及其制备方法和应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CN1027371C (zh) *	1989-09-08	1995-01-11	中国医学科学院皮肤病研究所	二萜内酯化合物的合成方法
US5663335A (en) *	1996-03-01	1997-09-02	Pharmagenesis, Inc.	Immunosuppressive compounds and methods
UA57757C2 (uk) *	1996-12-20	2003-07-15	Сос'Єте Де Консей Де Решерш Е Даплікасьон С'Єнтіфік (С.К.Р.А.С.)	Аналоги камптотецину, спосіб їх отримання (варіанти) і фармацевтична композиція
US5972998A (en) *	1997-05-23	1999-10-26	Hoechst Marion Roussel, Inc.	Triptolide derivatives useful in the treatment of autoimmune diseases

1999
- 1999-09-02 CA CA002342901A patent/CA2342901A1/en not_active Abandoned
- 1999-09-02 US US09/389,769 patent/US6150539A/en not_active Expired - Fee Related
- 1999-09-02 AU AU62425/99A patent/AU764123B2/en not_active Ceased
- 1999-09-02 AT AT03016090T patent/ATE334969T1/de not_active IP Right Cessation
- 1999-09-02 AT AT99949582T patent/ATE245145T1/de not_active IP Right Cessation
- 1999-09-02 DE DE69932649T patent/DE69932649T2/de not_active Expired - Fee Related
- 1999-09-02 EP EP99949582A patent/EP1109789B1/de not_active Expired - Lifetime
- 1999-09-02 CN CN99810578A patent/CN1316997A/zh active Pending
- 1999-09-02 DE DE69909633T patent/DE69909633T2/de not_active Expired - Fee Related
- 1999-09-02 WO PCT/US1999/020150 patent/WO2000012483A1/en not_active Ceased
- 1999-09-02 JP JP2000567513A patent/JP2002523495A/ja active Pending

Also Published As

Publication number	Publication date
US6150539A (en)	2000-11-21
JP2002523495A (ja)	2002-07-30
DE69932649D1 (de)	2006-09-14
DE69909633T2 (de)	2004-05-13
EP1109789A4 (de)	2002-01-02
DE69932649T2 (de)	2007-08-09
ATE245145T1 (de)	2003-08-15
AU764123B2 (en)	2003-08-07
EP1109789B1 (de)	2003-07-16
EP1109789A1 (de)	2001-06-27
WO2000012483A1 (en)	2000-03-09
DE69909633D1 (de)	2003-08-21
CN1316997A (zh)	2001-10-10
CA2342901A1 (en)	2000-03-09
AU6242599A (en)	2000-03-21

Legal Events

Date	Code	Title	Description
2007-02-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties

Publication	Publication Date	Title
ATE334969T1 (de)	2006-08-15	Triptolid-prodrugs mit hoher wasserlöslichkeit
PT907652E (pt)	2005-08-31	Compostos e processos imunossupressores
TR199801629A2 (xx)	1999-10-21	Fungisidal 2 -metoksibenzofenonlar.
DE69907977D1 (de)	2003-06-18	Pyrrolobenzodiazepine
FI954979A7 (fi)	1995-10-18	Kemoherkistävinä aineina käytettävät 10,11-metanodibentsosuberaanijohdannaiset
IS1806B (is)	2002-03-08	Arylthíósambönd sem varnarefni gegn bakteríum og veirum
BG103310A (en)	2000-05-31	Benzonaphthyridins as bronchial therapeutical means
WO2002070472A3 (en)	2002-10-24	Triptolide prodrugs having high aqueous solubility
ATE297904T1 (de)	2005-07-15	Halo-alkoxycarbonylverbindungen
ID16851A (id)	1997-11-13	Perintang yang ditingkatkan modulnya.
DE69930135D1 (de)	2006-04-27	Pseudomorphe transistoren mit hoher elektronenbeweglichkeit
DE60008400D1 (de)	2004-03-25	Triazolopyrimidinderivate
BR0109512A (pt)	2002-12-17	Imidazopiridinas tricìclicas
GT199500039BA (es)	1997-01-21	Compuestos ariltios
ITFI910067A0 (it)	1991-03-28	Attrezzatura per diamantare i bordi di catene ornamentali
ITMI930819A1 (it)	1994-10-27	Derivati eterobiciclici ad attivita' fungicida
ES2138362T4 (es)	2000-05-16	Derivados de citisina con contenido de fosforo.
ES2101531T3 (es)	1997-07-01	Derivados de benzo(f)quinoxalinadiona, su preparacion y su utilizacion en medicamentos.
TR199901284A2 (xx)	2000-01-21	Ester bile�imleri.
MY116769A (en)	2004-03-31	Immunosuppressive compounds and methods
ID26946A (id)	2001-02-22	Senyawa-senyawa baru
GB9911556D0 (en)	1999-07-21	Immunosuppressant tricyclic compounds
FI905213A0 (fi)	1990-10-23	Suganordning foer anvaendning vid tandvaord.
ECSP993064A (es)	1999-10-06	Compuestos organicos
IT9017950A1 (it)	1992-01-10	I due autorotanti.